BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220404T140000
DTEND;TZID=Europe/Stockholm:20220404T150000
DTSTAMP:20260407T011518
CREATED:20220316T072135Z
LAST-MODIFIED:20220331T055237Z
UID:10000559-1649080800-1649084400@www.scilifelab.se
SUMMARY:Information meeting – Call for Therapeutic Oligonucleotide Projects at OligoNova Hub / SciLifeLab DDD
DESCRIPTION:The mission of the Drug Discovery and Development Platform at SciLifeLab is to support researchers in developing new drugs\, transforming academic ideas into new treatments. Therapeutic oligonucleotides is a recent addition to the Drug Discovery and Development platform’s capacity\, available through the OligoNova Hub in Gothenburg.  \n\n\n\nNow\, the first call for therapeutic oligonucleotide projects is opening (March 28 – May 13\, 2022). \n\n\n\nAt this online information meeting\, there will be a presentation of the call and you as an applicant will have the opportunity to ask questions about the call and the application process.  \n\n\n\nThe call text will be published via the SciLifeLab and OligoNova websites on March 28. \n\n\n\nRegister here\n\n\n\n\n\n\n\nOligoNova Hub is a national facility providing academic researchers in Sweden with support and capabilities to convert ideas and discoveries into potential new oligonucleotide therapies. OligoNova Hub is part of the SciLifeLab Drug Discovery and Development platform\, and is located at the AZ BioVentureHub campus in Gothenburg. The OligoNova Hub offers full capacity for the design\, synthesis\, evaluation and optimization of therapeutic oligonucleotides to academic researchers. The hub has been made possible through support from the Knut and Alice Wallenberg foundation\, SciLifeLab\, University of Gothenburg\, Region Västra Götaland\, and a donation from Carl Bennet.
URL:https://www.scilifelab.se/event/information-meeting-call-for-therapeutic-oligonucleotide-projects-at-oligonova-hub-scilifelab-ddd/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="OligoNova - Part of the Drug Discovery and Development Platform":MAILTO:par.matsson@oligonova.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220404T140000
DTEND;TZID=Europe/Stockholm:20220404T150000
DTSTAMP:20260407T011518
CREATED:20220325T125600Z
LAST-MODIFIED:20220325T143719Z
UID:10000569-1649080800-1649084400@www.scilifelab.se
SUMMARY:Information Meeting: Call for therapeutic oligonucleotide projects
DESCRIPTION:This digital information meeting will be held April 4\, 2022 at 14.00–15.00. At this meeting\, there will be a presentation of the call and you as an applicant will have the opportunity to ask questions about the call and the application process. \n\n\n\nregister here to receive zoom link\n\n\n\nApply in the call here\n\n\n\nThe mission of the Drug Discovery and Development Platform at SciLifeLab is to support researchers in developing new drugs\, transforming academic ideas into new treatments. To this end\, the DDD platform provides state-of-the-art drug discovery technologies to scientists across the country. Therapeutic oligonucleotides are a recent addition to the DDD platform’s capacity\, complementing the previous focus on small molecule and protein drugs. Oligonucleotide drugs have different modes of action\, and a potentially faster development compared to other drug types. Therapeutic oligonucleotide development is supported by the OligoNova Hub\, based in Gothenburg and part of SciLifeLab’s DDD platform. \n\n\n\nIn this call\, we are looking for project ideas for new therapeutic oligonucleotides that can be developed at DDD and OligoNova Hub. Approved project ideas will be developed in close collaboration between the academic laboratory and drug development experts at DDD and OligoNova Hub. The costs of the projects will mainly be covered by OligoNova\, but academic partners will be expected to contribute by paying for reagent costs. \n\n\n\nThe call is open for scientists with a doctoral degree at a Swedish university or higher institution. English should be used when filling out this application. You are responsible for ensuring that the application is complete. Incomplete applications will not be processed. Attach only material that we explicitly request. SciLifeLab DDD/OligoNova will not accept additional information after the closing date for applications\, except for information we ourselves explicitly request. Applications are reviewed by a review committee with international representation. \n\n\n\nCall Announcement FlyerDownload\n\n\n\nThe call is open March 28\, 2022 to May 13\, 2022.
URL:https://www.scilifelab.se/event/information-meeting-call-for-therapeutic-oligonucleotide-projects/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220405T090000
DTEND;TZID=Europe/Stockholm:20220405T120000
DTSTAMP:20260407T011518
CREATED:20220121T160038Z
LAST-MODIFIED:20220121T160039Z
UID:10000513-1649149200-1649160000@www.scilifelab.se
SUMMARY:BioImage Analysis support - Call4Help
DESCRIPTION:Every 1st week of the month (mainly on Tuesdays\, but there might be exceptions) the BioImage Informatics Facility together with microscopy expert Sylvie Le Guyader (LCI\, Karolinska Institutet) organizes a Call4Help session. The aim is to offer combined expertise towards microscopy and bioimage analysis. All researchers from Swedish institutes can participate. \n\n\n\nThe ideal timepoint to join the Call4Help session is when a researcher has performed pilot experiments and has tried out first analysis approaches – but before having recorded hundreds of images. Combining BIIF’s expertise in BioImage Analysis with microscopy expertise we can discuss ways to record the images that allow analysis afterwards. We will discuss different analysis approaches using mainly open-source software (Fiji\, CellProfiler\, QuPath\, Ilastik\, KNIME)\, but also commercial systems\, if needed (Imaris). \n\n\n\nThe Call4Help session format has been introduced to the BioImage Analysis community by NEUBIAS and ScopeM. \n\n\n\nHow to participate? \n\n\n\nStep1: \n\n\n\nPrepare a short presentation (5-7 min)  – use the following template for your presentation: \n\n\n\nhttp://bit.ly/BIIF_C4H_slideTemplate \n\n\n\nSlide template by NEUBIAS/ScopeM \n\n\n\nStep2: \n\n\n\na) Upload your presentation \n\n\n\nUpload your presentation to a drive of your choice. You can also use our Call4Help google drive. Note that files shared on our Call4Help drive will be available to everyone until the session is over. \n\n\n\nhttp://bit.ly/BIIF_C4H_Drive \n\n\n\nb) Upload example images for testing. \n\n\n\nUpload example images for testing either to the drive of your choice or our Call4Help google drive above. \n\n\n\nhttp://bit.ly/BIIF_C4H_Drive \n\n\n\nc) Register by filling out the registration form: \n\n\n\nhttp://bit.ly/BIIF_C4H_Registration \n\n\n\nStep 3: \n\n\n\nJoin the zoom-session. \n\n\n\nIf your problem is selected for presentation\, you will get a time-slot of 30 – 60 minutes within the session. \n\n\n\nWhat are the Deadlines \n\n\n\nSubmission of a problem and upload of example data: Friday the week before the session. \n\n\n\nNotification about participation: The day before the session. \n\n\n\nNext Call4Help session \n\n\n\nTuesday\, April 5\, 2022\, 9.00-12.00. Deadline for application: Friday\, April 1\, 2022.
URL:https://www.scilifelab.se/event/bioimage-analysis-support-call4help-3/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="Bioimage Informatics Unit":MAILTO:biif@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220405T120000
DTEND;TZID=Europe/Stockholm:20220405T130000
DTSTAMP:20260407T011518
CREATED:20220315T135352Z
LAST-MODIFIED:20220318T161436Z
UID:10000557-1649160000-1649163600@www.scilifelab.se
SUMMARY:Unbiased characterization of cells using the single-cell facility
DESCRIPTION:In the frame of the “SciLifeLab Site Umeå / KBC Infrastructure Seminar Series”\, Johan Henriksson\, Research fellow at the Dept. of Molecular Biology & Molecular Infection Medicine Sweden (MIMS)\, will present the Single-cell facility. If you want to learn how you can benefit from single-cell analysis\, join for 30 min presentation of cases & opportunities\, followed by 30 min discussion of practicalities & project design. \n\n\n\nPresenter:Johan Henriksson\, Dept. Molecular Biology / Molecular Infection Medicine Sweden (MIMS) \n\n\n\nRegistration:To register your physical attendance and reserve your free sandwich\, please go to the Registration Link \n\n\n\nRegistration\n\n\n\nPhysical Attendance:Glasburen seminar roomChemical Biological Centre (KBC) BuildingUmeå University \n\n\n\nOnline Attendance:You can join the seminar on Zoom:https://umu.zoom.us/j/63138997026
URL:https://www.scilifelab.se/event/unbiased-characterization-of-cells-using-the-single-cell-facility/
LOCATION:Glasburen Seminar Room\, Chemical Biological Centre (KBC) Building\, Umeå University\, Umeå\, 901 87\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Ume%C3%A5":MAILTO:umea@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220405T153000
DTEND;TZID=Europe/Stockholm:20220405T163000
DTSTAMP:20260407T011518
CREATED:20220321T101658Z
LAST-MODIFIED:20220321T101728Z
UID:10000563-1649172600-1649176200@www.scilifelab.se
SUMMARY:Sustainability in Science: My Green Lab
DESCRIPTION:Cristalle Ruiz\n\n\n\nMarket Development Representative\, My Green Lab  \n\n\n\nResearchers in all stages of their career are welcome to attend and could find the talk useful. Kindly feel free to extend the invitation to your home universities. \n\n\n\nMy Green Lab is an internationally recognised non-profit organisation run by scientists aimed at introducing sustainable laboratory practices across the globe. We can find out more about My Green Lab’s mission\, the highly successful ‘Ambassador programme’ and other resources available from Cristalle Ruiz\, Market Development Representative of My Green Lab. The talk is intended to provide valuable insight into sustainability in science and the steps that could be implemented in our labs. \n\n\n\nCristalle Ruiz is the Market Development Representative for My Green Lab\, the leading global nonprofit supporting laboratory sustainability. Her role is to bring awareness to the benefits of sustainable practices across laboratories and manufacturers of laboratory products through My Green Lab’s market-leading programs. In her previous position\, Cristalle advocated for implementing renewable energy in the United States. She holds a bachelor’s degree in Environmental Business and Economics from Rutgers University. She will discuss and provide resources to build a culture of sustainability in the science industry. \n\n\n\n  \n\n\n\n \n\n\n\n PhD & Postdoc council (phd-council@scilifelab.se)
URL:https://www.scilifelab.se/event/sustainability-in-science-my-green-lab/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Solna PhD & Postdoc Council":MAILTO:phd-council@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220408T090000
DTEND;TZID=Europe/Stockholm:20220408T093000
DTSTAMP:20260407T011518
CREATED:20220330T131410Z
LAST-MODIFIED:20220330T132843Z
UID:10000574-1649408400-1649410200@www.scilifelab.se
SUMMARY:[Clinical Talks]Seeing is believing\, unraveling the discovery of a centimeter-long macro-bacteria
DESCRIPTION:On April 8\, Dr. Jean-Marie Volland\, Scientist at Berkeley Lab and Laboratory for Research in Complex Systems (LRC Systems)\, and Shailesh Date\, CEO of LRC Systems (Adj. Assoc. Professor at UCSF)\,will talk about their recent discovery and characterization of the macro-bacteria Ca. Thiomargarita magnifica. The threadlike single-cell bacterium\, commonly found in the Caribbean Mangroves\, is visible to the naked eye\, and able to grow up to 2 centimeters in length. In a recent effort\, an international team studied the “magnificent” organism using fluorescence\, x-ray\, and electron microscopy\, and fully sequenced the genome.  \n\n\n\nThrough a unique strategy of polyploidy\, along with compartmentalization of genomic material and protein synthesis in membrane-bound organelle\, the organism has been able to grow orders of magnitude over the theoretical limits for bacterial cells. The traditional view\, which has almost become dogmatic\, is that prokaryotes (bacteria and single-cell microbes) have free-floating DNA\, whereas eukaryotes (yeast and multicellular organisms) package their DNA in a nucleus. This new model organism blurs that line and offers amazing potential insights into biological evolutionary strategies\, many of which are as yet unexplored. One can only wonder at the type and number of new clinical innovations that will emerge as we continue exploring the frontiers of biology and biological complexity. \n\n\n\nRegister to receive zoom link\n\n\n\n  \n\n\n\n\n\n\n\nJean-Marie Volland is a Scientist at Lawrence Berkeley National Laboratory (Berkeley Lab) and at Laboratory of Research in Complex Systems (LRC Systems) in Menlo Park California. He obtained his PhD at the Université des Antilles\, in the French West Indies\, studying biology and tropical ecology in the Indian Ocean and Caribbean. Jean-Marie then continued to pursue his Postdoctoral research at University of Vienna\, Austria during 2012-2017. Initially in the Monika Bright´s Lab at the Department of Limnology and Biological Oceanography studying symbiosis in chemosynthetic ecosystems\, and then also in the Silvia Bulgheresi´s Lab at the Archea Biology and Ecogenomics Division studying tropical ecology pathways of microorganisms. In 2018 Jean-Marie joined the Berkeley Lab as an affiliate Scientist to continue working on uncovering highly divergent forms of life together with LRC Systems. The story of the discovery of Thiomargarita magnifica dates back a decade ago\, when marine biologist Olivier Gros\, from the Université of Antilles\, first discovered microbial filaments on leaves buried in the mangrove of Guadeloupe. Gros lab member and microbiologist colleague Silvina González-Rizzo identified it to be in fact be one bacterium. Jean-Marie\, together with his Université of Antilles colleagues and LRC Systems set forth to methodologically study and categorize the new organism. \n\n\n\n\n\n\n\nShailesh Date is the CEO and Founder of Laboratory for Research in Complex Systems (LRC Systems). He is also Adjunct Professor of Biology at San Francisco State University and an Associate Adjunct Professor of Epidemiology and Biostatistics at the University of California San Francisco (UCSF). Shailesh obtained his PhD at The University of Texas\, Austin in Molecular Biology in 2004\, and completed a postdoctoral fellowship at the University of Pennsylvania School of Medicine in 2008\, focusing on computational biology of infectious diseases. Between 2008-2015\, Shailesh worked as a scientist at Genentech\, and during a brief sabbatical in 2013\, completed the prestigious Ignite Program at the Stanford Graduate School of Business. He left Genentech in 2015 to join Global Viral (GV)\, a nonprofit organization with roots in public health research. He founded the LRC Systems in 2019\, transforming Global Viral into a new organization focused on complex systems research in a wide variety of areas. \n\n\n\nAbout Global Viral and LRC SystemsGlobal Viral was founded by Nathan Wolfe in 2007 as the Global Viral Forecasting Initiative (GVFI)\, focusing on public health and field epidemiology while supporting programs like HIV prevention run by USAID\, WHO and other similar organizations in Africa and South East Asia.In 2012\, the organization split into Metabiota\, a for-profit company that took over epidemiology and forecasting-related work\, and Global Viral\, a nonprofit that retained and concentrated on basic research.In 2019\, under the leadership of a new Chief Executive and a new board\, the organization reoriented its research towards complex systems and adopted the “Laboratory for Research in Complex Systems (LRC Systems)”\, which was initially founded as a new division within GV\, as its new name.https://www.lrc.systems \n\n\n\n\n\n\n\n\n“Clinical Talks” has been renewed for yet another exciting\, innovative\, and enlightening season. This season will focus on sustainable innovations within Life Sciences\, that have the potential to contribute to a better climate friendly future for our future generations. Also new this year is that the seminar is co-organized in a collaboration between SciLifeLab and KI Innovations . \n\n\n\nSeason 5\, will be held September 2021 until March 2022 with scheduled Talks\, during Friday mornings 09-09:30 am via ZOOM (with some time-zone friendly adjustments for our international speakers). Each session consists of a talk given by our invited speaker followed by Q&A. The seminar is an open educational seminar series for our ever-expanding Life Science community.
URL:https://www.scilifelab.se/event/seeing-is-believing-unraveling-the-discovery-of-ca-thiomargarita-magnifica-a-centimeter-long-macro-bacteria/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220411T151500
DTEND;TZID=Europe/Stockholm:20220411T161500
DTSTAMP:20260407T011518
CREATED:20220315T160745Z
LAST-MODIFIED:20220404T080634Z
UID:10000558-1649690100-1649693700@www.scilifelab.se
SUMMARY:Decreased levels of oxygen radicals cause autoimmune disease.
DESCRIPTION:Prof. Rikard Holmdahl \n\n\n\nKarolinska Institute\, Sweden \n\n\n\nRegister HERE\n\n\n\nRikard Holmdahl made his PhD (1985) and MD (1987) at Uppsala University. Professor in medical inflammation research Lund University 93-07. Professor at Karolinska Institute from 2008 \n\n\n\n\n\n\n\nVenue: Hybrid meeting – Trippelrummet\, Navet and zoom \n\n\n\n\n\n\n\n\n\n \n\n\n\nTitle of the seminar: Finding and understanding genes associated with common diseases; decreased levels of oxygen radicals cause autoimmune disease\n\n\n\nA long-standing challenge is to understand which genes that cause common complex diseases\, such as rheumatoid arthritis\, atherosclerosis or cancer\, and thereby understand the disease causes. However\, even though we know the human sequence and can genotype millions of individuals it is very difficult to conclusively identify the single nucleotide variants that cause the diseases. We have taken another approach through animal models. Both genetics and diseases show similarities with humans\, and we have shown that it is possible to not only identify the loci associated with disease but also exactly position the polymorphic nucleotides for common autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).  \n\n\n\nI will focus on the first gene that we cloned\, Ncf1\, which regulate immune tolerance through different levels of oxygen radicals\, or more precisely hydrogen peroxide. It is the major gene causing SLE and is important in Sjögren’s syndrome and RA and most likely most autoimmune disease. \n\n\n\nTo understand the role of Ncf1 is also complicated as peroxide seem to regulate many different pathways leading to autoimmune diseases. I will discuss how we think it regulates RA and SLE but also how it could explain our normal behaviour\, thus explaining why Ncf1 variants are common in both rat and human population. \n\n\n\nRead more about ikard Holmdahl´s research http://ki.se/en/mbb/research-division-of-medical-inflammation-research
URL:https://www.scilifelab.se/event/decreased-levels-of-oxygen-radicals-cause-autoimmune-disease/
LOCATION:Navet\, SciLifeLab Uppsala\, SciLifeLab Uppsala\, BMC C11\, Husargatan 3\, Uppsala\, 75237\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2022/02/Picture1-The-Svedberg.png
ORGANIZER;CN="The Svedberg Seminar Series":MAILTO:thesvedberg@scilifelab.uu.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220412T003000
DTEND;TZID=Europe/Stockholm:20220412T010000
DTSTAMP:20260407T011518
CREATED:20220412T121106Z
LAST-MODIFIED:20220715T121407Z
UID:10000582-1649723400-1649725200@www.scilifelab.se
SUMMARY:γδSTO workshop –  Mini-symposium of Stockholm’s γδ T cell community
DESCRIPTION:A workshop on the May 5\, on gamma delta T cells for our scientific community in Stockholm. Different labs from SciLifeLab\, KI (Solna and Fleminsberg) and Stockholm University are invited. \n\n\n\nProgram: \n\n\n\n13:15 / Introduction \n\n\n\nTaras Kreslavskiy(KI): Transcriptome-wide screen for γδTCR specificities identifies a novel superantigen-like ligand candidate for Vγ7 γδTCRs \n\n\n\nLola Boutin (KI): Evaluation of the potential of using non-conventional (NC) T cell- based immunotherapy in Medulloblastoma \n\n\n\nPatrick Sandoz (KTH): Dynamics of Vγ9Vδ2 T cell cytotoxic functions at the single-cell level \n\n\n\n14:30 / Coffee break \n\n\n\nFaisal Alagrafi (KI):γδ T cells reconstitution in long term survivors after hematopoietic stem cell transplantation \n\n\n\nClàudiaArasa(SU): Functional characteristics of γδ T cells in prematurity and early life\, and their response to staphylococcal enterotoxins \n\n\n\nJulius Lautenbach (KI): Systems level analysis indicates an interplay between cytophilic antibodies\, monocytes\, and γδ T cells in malaria tolerance \n\n\n\n16:15 / Drinks and Discussion (γ2 lunchroom)
URL:https://www.scilifelab.se/event/%ce%b3%ce%b4sto-workshop-mini-symposium-of-stockholms-%ce%b3%ce%b4-t-cell-community/
LOCATION:Navet\, SciLifeLab Uppsala\, SciLifeLab Uppsala\, BMC C11\, Husargatan 3\, Uppsala\, 75237\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2022/03/infrastructure.png
ORGANIZER;CN="SciLifeLab Data Centre":MAILTO:datacentre@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220413T151500
DTEND;TZID=Europe/Stockholm:20220413T164500
DTSTAMP:20260407T011518
CREATED:20220315T132014Z
LAST-MODIFIED:20220331T120240Z
UID:10000555-1649862900-1649868300@www.scilifelab.se
SUMMARY:SciLifeLab COVID-19 seminar: Jinal Bhiman and Vicent Pelechano
DESCRIPTION:Topic: Detection of virus \n\n\n\nThe second SciLifeLab COVID-19 seminar this spring starts with Jinal Bhiman\, PhD and Scientific lead for the Global Immunology and Immune Sequencing South Africa (GIISER-SA)\, talking about SARS-CoV-2 viral evolution in South Africa and hybrid immunity profiles. Vicent Pelechano\, PhD\, SciLifeLab and Wallenberg Academy Fellow and Principal Researcher at Karolinska Institutet\, then continues the seminar with his talk on Development of LAMP-based point of care strategies for simplified SARS-CoV-2 detection \n\n\n\n\n\n\n\nSchedule \n\n\n\n15:15- 16:00 – SARS-CoV-2 viral evolution in South Africa and hybrid immunity profiles                        Jinal Bhiman\, PhD and Scientific lead for the Global Immunology and Immune Sequencing South Africa (GIISER-SA)16:00-16:45 – Development of LAMP-based point of care strategies for simplified SARS-CoV-2 detection                       Vicent Pelechano\, PhD\, SciLifeLab and Wallenberg Academy Fellow and Principal Researcher at Karolinska Institutet\n\n\n\n\n\n\n\nRegistration is mandatory to get the Zoom link for the event  \n\n\n\n\nREGISTRATION\n\n\n\nBIOS & ABSTRACTS
URL:https://www.scilifelab.se/event/scilifelab-covid-19-seminar-jinal-bhiman-and-vicent-pelechano-online/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2021/05/covid_3d_model-min-1536x864-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220421T110000
DTEND;TZID=Europe/Stockholm:20220421T120000
DTSTAMP:20260407T011518
CREATED:20220323T161559Z
LAST-MODIFIED:20220323T161633Z
UID:10000567-1650538800-1650542400@www.scilifelab.se
SUMMARY:WGS & WTS – gamechangers in AML and ALL diagnostics
DESCRIPTION:Speaker: Manja Meggendorfer\, Head of Molecular Genetics at MLL Munich Leukemia Laboratory \n\n\n\nThe webinar is jointly organized by the Unit of Clinical Genetics at the Department of Molecular Medicine\, KI\, the Clinical Genomics platform and Genomic Medicine Sweden. \n\n\n\n \n\n\n\nRegister to receive zoom link
URL:https://www.scilifelab.se/event/wgs-wts-gamechangers-in-aml-and-all-diagnostics/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2022/03/Seminar_Manja-Meggendorfer.png
ORGANIZER;CN="Clinical Genomics Platform":MAILTO:marcela.davila@gu.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220421T150000
DTEND;TZID=Europe/Stockholm:20220421T160000
DTSTAMP:20260407T011518
CREATED:20220330T110000Z
LAST-MODIFIED:20220421T112532Z
UID:10000573-1650553200-1650556800@www.scilifelab.se
SUMMARY:FAIRPoints-Things you need to know about Data Access Statements
DESCRIPTION:Location: Online via Zoom \n\n\n\n\n\nSee Event in your Time Zone \n\n\n\nSpeaker: Juliane Schneider & Chris Erdmann \n\n\n\nSpeakers Juliane Bio\, Chris Bio \n\n\n\nFAIRPoints is an event series highlighting pragmatic measures developed by the community towards the implementation of the FAIR (Findable\, Accessible\, Interoperable\, Reusable) data principles\, in collaboration with GoFAIR US\, SDSC\, AGU\, and SciLifeLab Data Centre.  \n\n\n\nData access statements (DAS)\, also known as data availability statements\, are key elements that can be used in multiple diverse disciplines and have a huge impact in providing essential information as it outlines where and how any underlying data may be accessed and reused\, listing specific restrictions (if any) and authorization requirements. It is therefore integral to the FAIRification process.  \n\n\n\nJoin us in this talk to discover how an effective data access statement should look like!  \n\n\n\n\n\n\n\nRegister here\n\n\n\nSign up for future events here \n\n\n\nTwitter: @FAIR_Points
URL:https://www.scilifelab.se/event/fairpoints-das/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220422T090000
DTEND;TZID=Europe/Stockholm:20220422T093000
DTSTAMP:20260407T011518
CREATED:20220330T133354Z
LAST-MODIFIED:20220405T153635Z
UID:10000575-1650618000-1650619800@www.scilifelab.se
SUMMARY:[Clinical Talks] Introduction to AI-driven image analysis in pathology: from preclinical research to clinical diagnostics
DESCRIPTION:Dr. Sami Blom leads Aiforia’s application development team with an ambition to build impactful image analysis solutions to advance histopathology. He has a background in the fields of translational cancer research and pathology and he has extensive expertise in staining and imaging methods for histology specimens. Dr. Blom joined Aiforia in 2016 to develop and advance Aiforia’s applications\, products and services. \n\n\n\nIntroduction to AI-driven image analysis in pathology: from preclinical research to clinical diagnostics \n\n\n\nAiforia equips pathologists and scientists with powerful deep learning artificial intelligence for translating images into discoveries\, decisions\, and diagnoses. The cloud based Aiforia software aims to escalate the efficiency and precision of preclinical and clinical medical image analysis from oncology to neuroscience and more. Deep learning artificial intelligence enables increased speed\, accuracy and consistency in medical image analysis.  \n\n\n\nAiforia was founded in 2013 and our mission is to provide the highest quality solutions for AI-assisted image analysis to enable personalized and democratized care for patients. Year 2021 was historic for the company: Aiforia was listed on Nasdaq Helsinki First North Market Finland in December 2021. In connection with the listing\, the Company raised approximately 29 million euros in gross assets. This\, together with the B-financing round implemented earlier in the same year\, provides a strong foundation for Aiforia’s growth. \n\n\n\nRegister to receive zoom link\n\n\n\n \n\n\n\n\n“Clinical Talks” has been renewed for yet another exciting\, innovative\, and enlightening season. This season will focus on sustainable innovations within Life Sciences\, that have the potential to contribute to a better climate friendly future for our future generations. Also new this year is that the seminar is co-organized in a collaboration between SciLifeLab and KI Innovations . \n\n\n\nSeason 5\, will be held September 2021 until March 2022 with scheduled Talks\, during Friday mornings 09-09:30 am via ZOOM (with some time-zone friendly adjustments for our international speakers). Each session consists of a talk given by our invited speaker followed by Q&A. The seminar is an open educational seminar series for our ever-expanding Life Science community.
URL:https://www.scilifelab.se/event/clinical-talks-introduction-to-ai-driven-image-analysis-in-pathology/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220426T093000
DTEND;TZID=Europe/Stockholm:20220426T120000
DTSTAMP:20260407T011518
CREATED:20220411T114853Z
LAST-MODIFIED:20220411T115121Z
UID:10000581-1650965400-1650974400@www.scilifelab.se
SUMMARY:New developments in upstream bioprocessing technologies seminar
DESCRIPTION:Presentation och demonstration av nya single use bioreactors (SUB) för mammalieceller.  \n\n\n\nregister to attend\n\n\n\nProgram:  \n\n\n\n9:30-10:15 Matthijs Neimeijer\, Cultivating red blood cells in singe-use bioreactors \n\n\n\n10:15-10:45 Fika och demonstration \n\n\n\n10:45-11:30 Michel Kensler\, Comparisons in scale up and down scale \n\n\n\n11:30-12:00 Questions
URL:https://www.scilifelab.se/event/new-developments-in-upstream-bioprocessing-technologies-seminar/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220426T120000
DTEND;TZID=Europe/Stockholm:20220426T130000
DTSTAMP:20260407T011518
CREATED:20220411T113030Z
LAST-MODIFIED:20220411T113031Z
UID:10000580-1650974400-1650978000@www.scilifelab.se
SUMMARY:Measuring metabolites\, the building blocks of biology
DESCRIPTION:In the frame of the SciLifeLab Site Umeå / KBC Infrastructure Seminar Series\, the seminars will be organised every second Tuesday during spring 2022 in turn with IceLab Lunch Pitches. The seminars will be held in a hybrid format IRL in Glasburen\, KBC\, and online via Zoom. Take the chance to get information on facilities\, possibilities and services that infrastructure\, both SciLifeLab-associated and local\, can offer! Learn more about the seminar series and Schedule for Spring 2022 here. \n\n\n\nOn April 26th\, 12:00-13:00\, SciLifeLab Site Umeå / KBC Infrastructure Seminar Series presents:  \n\n\n\n“Measuring metabolites\, the building blocks of biology” \n\n\n\nby Annika Johansson\, Head of the Swedish Metabolomics Centre (SMC) facility. \n\n\n\nThe presentation will give an introduction to metabolomics and small molecule analysis by mass spectrometry. We will present our different services and also give examples of different research projects in which SMC has been involved. \n\n\n\nLearn more about the Swedish Metabolomics Centre on its homepage. \n\n\n\nSign up (latest by April 25th\, 10 a.m.) for on-site participation or follow online via Zoom: https://umu.zoom.us/j/63138997026 \n\n\n\nregistration
URL:https://www.scilifelab.se/event/measuring-metabolites-the-building-blocks-of-biology/
LOCATION:Glasburen Seminar Room\, Chemical Biological Centre (KBC) Building\, Umeå University\, Umeå\, 901 87\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Ume%C3%A5":MAILTO:umea@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220427T140000
DTEND;TZID=Europe/Stockholm:20220427T153000
DTSTAMP:20260407T011518
CREATED:20220420T102001Z
LAST-MODIFIED:20220420T102506Z
UID:10000584-1651068000-1651073400@www.scilifelab.se
SUMMARY:Developmental origins of cell heterogeneity in the human lung
DESCRIPTION:HDCA Seminar Series 2022 | Lung \nChristo Samakovlis and Alexandros Sountoulidis \nThe lung contains numerous specialized cell-types with distinct roles in tissue function and integrity. To clarify the origins and mechanisms generating cell heterogeneity\, we created a first comprehensive topographic atlas of early human lung development. We report 83 cell states\, several spatially-resolved developmental trajectories and predict cell interactions within defined tissue niches. We integrated scRNA-Seq and spatial transcriptomics into a web-based\, open platform for interactive exploration. To illustrate the utility of our approach we show distinct states of secretory and neuroendocrine cells\, largely overlapping with the programs activated either during lung fibrosis or small cell lung cancer progression. We define the origin of uncharacterized airway fibroblasts associated with airway smooth muscle in bronchovascular bundles\, and describe a trajectory of Schwann cell progenitors to intrinsic parasympathetic neurons controlling bronchoconstriction. Our atlas provides a rich resource for further research and a reference for defining deviations from homeostatic and repair mechanisms leading to pulmonary diseases. \n  \n– \nHuman developmental cell atlas (HDCA) is the Swedish effort within the human cell atlas (HCA)\, one of the largest international scientific projects. The project aim is to create a comprehensive molecular atlas of human prenatal development at the molecular resolution using state-of-the-art multi-omic technologies such as single-cell RNA-seq\, Spatial Transcriptomics\, in situ sequencing in order to provide deeper insight into how variations and deviations contribute to health and disease. \nThe HDCA Seminar Series 2022 invites you to join us on a journey of early human organogenesis of several organs at the single-cell and spatial resolution. Seminars will be held at SciLifeLab Gamma building on Wednesdays at 14:00 or 15:00 and also via Zoom. After each seminar\, we will have up to 30 min round up discussions with the speaker on how you can contribute to the atlas!  \nWarm Welcome! \n  \n\n\nregistration
URL:https://www.scilifelab.se/event/developmental-origins-of-cell-heterogeneity-in-the-human-lung/
LOCATION:Gamma 2 Lunchroom\, SciLifeLab\, Tomtebodavägen 23\, Solna\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2022/04/logo_hdca2.png
ORGANIZER;CN="The Human Developmental Cell Atlas":MAILTO:hdca-sweden@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220428T080000
DTEND;TZID=Europe/Stockholm:20220429T170000
DTSTAMP:20260407T011518
CREATED:20220308T124733Z
LAST-MODIFIED:20220308T142609Z
UID:10000547-1651132800-1651251600@www.scilifelab.se
SUMMARY:Nordic Precision Medicine Forum
DESCRIPTION:Just prior to the pandemic Sweden launched its first ever national Life Science Strategy in eight priority areas covering the strengthening of academic research\, facilitating collaboration between academia and industry\, attracting more industry initiated clinical trials\, and the continuous skills development needed for precision medicine and highly advanced production of pharmaceuticals and medtech devices. Across the Nordic countries precision medicine and technology developments continue at pace\, truly putting them in a favourable position when it comes to taking on the opportunities and challenges of implementing precision medicine\, with its promise to really transform future healthcare as well as the entire life science sector. \n\n\n\nSince 2016 we have convened the regions leading scientists\, healthcare practitioners\, and industry pioneers at our annual meeting. For 2022 you can expect a whole lot more interaction as we finally get back to in-person events. \n\n\n\nRead more\n\n\n\nWe very much hope to see you in Stockholm in April 2022 and hope that you and your loved ones remain safe and healthy throughout these troubling times.
URL:https://www.scilifelab.se/event/nordic-precision-medicine-forum/
LOCATION:Hotel Birger Jarl\, Birger Jarlsgatan 61\, Stockholm\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220428T170000
DTEND;TZID=Europe/Stockholm:20220428T190000
DTSTAMP:20260407T011518
CREATED:20220420T143019Z
LAST-MODIFIED:20220420T143132Z
UID:10000587-1651165200-1651172400@www.scilifelab.se
SUMMARY:Matchmaking Event – Data Science and Medical/Clinical Research
DESCRIPTION:Welcome to a matchmaking event between researchers within Data Science and Medical/Clinical research at KTH and Region Stockholm. The event is related to the project call: Health\, Medicine and Technology 2023. \n\n\n\nRead more\n\n\n\nRegion Stockholm and KTH opened the yearly call for collaboration in Health\, Medicine and Technology 14 April\, 2022. A key requirement to apply for this call is that one of the partners should be from KTH and one from Region Stockholm. With this event\, we hope to encourage collaborations between experts in data science and clinical research\, at KTH and Region Stockholm. The event is open for all researchers from KTH and from Region Stockholm who are eligible to submit a grant proposal for the Health\, Medicine and Technology Project Call. Postdoctoral researchers who can be co-PI are also encouraged to attend the event. Should you have any questions\, please contact: lifescienceplatform@kth.se ordigitalizationplatform@kth.se \n\n\n\nThe event is organised by the KTH Life Science Platform and KTH Digitalization Platform
URL:https://www.scilifelab.se/event/matchmaking-event-data-science-and-medical-clinical-research/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220429T140000
DTEND;TZID=Europe/Stockholm:20220429T150000
DTSTAMP:20260407T011518
CREATED:20220315T091430Z
LAST-MODIFIED:20220315T134837Z
UID:10000553-1651240800-1651244400@www.scilifelab.se
SUMMARY:AI-driven genomic precision diagnostics in hematologic malignancies
DESCRIPTION:In this webinar\, jointly organized by the Clinical Genomics platform and Genomic Medicine Sweden\, Dr. Aziz Nazha will present AI-based solutions to improve the diagnosis\, prognosis\, and selection of therapy in hematologic malignancies. The talk will also cover the clinical implication of AI/ML in diagnostic hematology\, current challenges and potential future opportunities. \n\n\n\n\n\n\n\nRegister to receive zoom link\n\n\n\n\n\n\n\nHost: Thoas Fioretos\, Director Clinical Genomics platform \n\n\n\nShort bio:  Aziz Nazha\, MD\, is currently a Global Tech Business Development for Healthcare Solutions at Amazon Web Services. Prior to joining Amazon\, Dr. Nazha was the director of the Cleveland Clinic Center for Clinical Artificial Intelligence and an Associate Medical Director at Enterprise Analytics. He is also an internationally recognized expert in treating patients with leukemia. His research focuses on the use of artificial intelligence\, machine learning\, and deep learning to translate genomic and complex healthcare data into useful clinical tools that can improve patient outcomes.
URL:https://www.scilifelab.se/event/ai-driven-genomic-precision-diagnostics-in-hematologic-malignancies/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2022/03/Banner-Clinical-Genomics-GMS.jpg
ORGANIZER;CN="Clinical Genomics Platform":MAILTO:marcela.davila@gu.se
END:VEVENT
END:VCALENDAR